Comorbidity as a predictor of survival in veterans with stage I and II non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Boholli, I.
Hoover, D.
Yang, W. M.
Abanonu, C.
Gonzalez, M.
Kasimis, B.
Chang, V. T.
机构：
[1] UMDNJ Sch Publ Hlth, Newark, NJ USA
[2] Rutgers State Univ, Piscataway, NJ USA
[3] VA New Jersey Hlth Care Syst, E Orange, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e16605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16605
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of comorbidity and age on survival among older veterans with early stage non-small cell lung cancer (NSCLC).
    Wong, Melisa L.
    Wang, Sunny
    Shi, Ying
    Wozniak, Curtis J.
    Walter, Louise C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Impact of comorbidity on survival in untreated stage I and II non-small cell lung cancer: A retrospective analysis
    Sahmoun, A
    Chadha, A
    [J]. LUNG CANCER, 2005, 49 : S285 - S286
  • [3] Radiation therapy of stage I and II non-small cell lung cancer (NSCLC)
    Zierhut, D
    Bettscheider, C
    Schubert, K
    van Kampen, M
    Wannenmacher, M
    [J]. LUNG CANCER, 2001, 34 : S39 - S43
  • [4] Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
    Chang, V. T.
    Hoover, D. R.
    Cogswell, J.
    Cholankeril, M.
    Badin, S.
    Yang, W.
    Yan, H.
    Gonzalez, M. L.
    Einhorn, J.
    Kasimis, B. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Lymphopenia as a predictor of survival in chemoradiation (CRT)-treated stage III non-small cell lung cancer (NSCLC).
    Yellu, Mahender
    Fakhrejahani, Farhad
    Ying, Jun
    Mierzwa, Michelle
    Malek, Ehsan
    Haque, Sulsal
    Sendilnathan, Arun
    Huth, Bradley Joseph
    Morris, John Charles
    Karim, Nagla Abdel
    Latif, Tahir
    Redmond, Kevin P.
    Barrett, William
    Videtic, Gregory M. M.
    Sadraei, Nooshin Hashemi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC)
    Soussi, Ghassen
    Racil, Hajer
    Bacha, Saoussen
    Rouhou, Sana Cheikh
    Zidi, Asma
    Ayadi, Aida
    Chaouch, Nawel
    Chabbou, Abdellatif
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] Proton therapy for stage I non-small cell lung cancer (NSCLC)
    Nihei, K
    Ogino, T
    Ishikura, S
    Nishimura, H
    Kawashima, M
    Arahira, S
    Onozawa, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S282 - S282
  • [8] Video-assisted lobectomy for non-small cell lung cancer (NSCLC) stage I and II
    Hecker, Erich
    Welcker, Katrin
    Schumm, Friedrich
    Schlolaut, Bettina
    [J]. CHEST, 2006, 130 (04) : 271S - 272S
  • [9] Comorbidity and survival for patients with advanced-stage non-small cell lung cancer
    Chrischilles, Elizabeth A.
    Abu Hejleh, Taher
    Carter, Knute D.
    Pendergast, Jane F.
    Halfdanarson, Thorvardur Ragnar
    Fletcher, Robert H.
    Wallace, Robert B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Therapy for stage I and stage II non-small cell lung cancer
    Tanoue, LT
    Ponn, RB
    [J]. CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 173 - +
12345